Clinical Trial Update: Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ilaprazole for the treatment of duodenal ulcer in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer

Drugs mentioned

• Ilaprazole (ilaprazole)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Duodenal Ulcer | Phase 3 | Status: COMPLETED